Cite
Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.
MLA
Falsey, Ann R., et al. “Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.” Journal of Infectious Diseases, vol. 198, no. 9, Nov. 2008, pp. 1317–26. EBSCOhost, https://doi.org/10.1086/592168.
APA
Falsey, A. R., Walsh, E. E., Capellan, J., Gravenstein, S., Zambon, M., Yau, E., Gorse, G. J., Edelman, R., Hayden, F. G., McElhaney, J. E., Neuzil, K. M., Nichol, K. L., Simões, E. A. F., Wright, P. F., & Sales, V. M.-P. (2008). Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals. Journal of Infectious Diseases, 198(9), 1317–1326. https://doi.org/10.1086/592168
Chicago
Falsey, Ann R., Edward E. Walsh, Jose Capellan, Stefan Gravenstein, Maria Zambon, Eddy Yau, Geoffrey J. Gorse, et al. 2008. “Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.” Journal of Infectious Diseases 198 (9): 1317–26. doi:10.1086/592168.